title: Drug-Drug Interactions in Patients Co-infected With HCV and HIV--Reply.
authors.affiliation: Institute of Human Virology, University of Maryland, Baltimore.
authors.forename: Anu
authors.initials: A
authors.lastname: Osinusi
authors.affiliation: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
authors.forename: Kerry
authors.initials: K
authors.lastname: Townsend
authors.affiliation: Institute of Human Virology, University of Maryland, Baltimore.
authors.forename: Shyam
authors.initials: S
authors.lastname: Kottilil
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D005260:Female; D005449:Fluorenes / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D014542:Uridine Monophosphate / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D005449:Fluorenes; D014542:Uridine Monophosphate